607 related articles for article (PubMed ID: 28244658)
61. Global research trend and hotspot in the low FODMAP diet: a bibliometric analysis.
Xu C; Song Z; Hu JY; Li CC; Shen H
J Health Popul Nutr; 2024 May; 43(1):63. PubMed ID: 38741213
[TBL] [Abstract][Full Text] [Related]
62. A Retrospective Study on Dietary FODMAP Intake in Celiac Patients Following a Gluten-Free Diet.
Roncoroni L; Elli L; Doneda L; Bascuñán KA; Vecchi M; Morreale F; Scricciolo A; Lombardo V; Pellegrini N
Nutrients; 2018 Nov; 10(11):. PubMed ID: 30445688
[TBL] [Abstract][Full Text] [Related]
63. Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis.
Black CJ; Staudacher HM; Ford AC
Gut; 2022 Jun; 71(6):1117-1126. PubMed ID: 34376515
[TBL] [Abstract][Full Text] [Related]
64. FODMAPs, inflammatory bowel disease and gut microbiota: updated overview on the current evidence.
Simões CD; Maganinho M; Sousa AS
Eur J Nutr; 2022 Apr; 61(3):1187-1198. PubMed ID: 34988652
[TBL] [Abstract][Full Text] [Related]
65. Intestinal microbiota fingerprint in subjects with irritable bowel syndrome responders to a low FODMAP diet.
Valdez-Palomares F; Nambo-Venegas R; Uribe-García J; Mendoza-Vargas A; Granados-Portillo O; Meraz-Cruz N; Palacios-González B
Food Funct; 2021 Apr; 12(7):3206-3218. PubMed ID: 33877245
[TBL] [Abstract][Full Text] [Related]
66. Controversies and reality of the FODMAP diet for patients with irritable bowel syndrome.
Halmos EP; Gibson PR
J Gastroenterol Hepatol; 2019 Jul; 34(7):1134-1142. PubMed ID: 30945376
[TBL] [Abstract][Full Text] [Related]
67. Gastrointestinal effects of diets low in fermentable oligosaccharides, disaccharides, monosaccharides and polyols.
Quigley EMM
Curr Opin Clin Nutr Metab Care; 2022 Jul; 25(4):260-264. PubMed ID: 35762162
[TBL] [Abstract][Full Text] [Related]
68. Bioelectrical impedance vector analysis in patients with irritable bowel syndrome on a low FODMAP diet: a pilot study.
Bellini M; Gambaccini D; Bazzichi L; Bassotti G; Mumolo MG; Fani B; Costa F; Ricchiuti A; De Bortoli N; Mosca M; Marchi S; Rossi A
Tech Coloproctol; 2017 Jun; 21(6):451-459. PubMed ID: 28567692
[TBL] [Abstract][Full Text] [Related]
69. Role of FODMAPs in Patients With Irritable Bowel Syndrome.
Mansueto P; Seidita A; D'Alcamo A; Carroccio A
Nutr Clin Pract; 2015 Oct; 30(5):665-82. PubMed ID: 25694210
[TBL] [Abstract][Full Text] [Related]
70. A Low-FODMAP Diet for Irritable Bowel Syndrome: Some Answers to the Doubts from a Long-Term Follow-Up.
Bellini M; Tonarelli S; Barracca F; Morganti R; Pancetti A; Bertani L; de Bortoli N; Costa F; Mosca M; Marchi S; Rossi A
Nutrients; 2020 Aug; 12(8):. PubMed ID: 32784614
[TBL] [Abstract][Full Text] [Related]
71. A randomized controlled trial investigating the effect of a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols on the intestinal microbiome and inflammation in patients with ulcerative colitis: study protocol for a randomized controlled trial.
Milajerdi A; Sadeghi O; Siadat SD; Keshavarz SA; Sima A; Vahedi H; Adibi P; Esmaillzadeh A
Trials; 2020 Feb; 21(1):201. PubMed ID: 32070388
[TBL] [Abstract][Full Text] [Related]
72. Managing irritable bowel syndrome: The low-FODMAP diet.
Dugum M; Barco K; Garg S
Cleve Clin J Med; 2016 Sep; 83(9):655-62. PubMed ID: 27618353
[TBL] [Abstract][Full Text] [Related]
73. Using eHealth strategies in delivering dietary and other therapies in patients with irritable bowel syndrome and inflammatory bowel disease.
Ankersen DV; Carlsen K; Marker D; Munkholm P; Burisch J
J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():27-31. PubMed ID: 28244677
[TBL] [Abstract][Full Text] [Related]
74. AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert Review.
Chey WD; Hashash JG; Manning L; Chang L
Gastroenterology; 2022 May; 162(6):1737-1745.e5. PubMed ID: 35337654
[TBL] [Abstract][Full Text] [Related]
75. Diets that differ in their FODMAP content alter the colonic luminal microenvironment.
Halmos EP; Christophersen CT; Bird AR; Shepherd SJ; Gibson PR; Muir JG
Gut; 2015 Jan; 64(1):93-100. PubMed ID: 25016597
[TBL] [Abstract][Full Text] [Related]
76. Clinical effectiveness and economic costs of group versus one-to-one education for short-chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndrome.
Whigham L; Joyce T; Harper G; Irving PM; Staudacher HM; Whelan K; Lomer MC
J Hum Nutr Diet; 2015 Dec; 28(6):687-96. PubMed ID: 25871564
[TBL] [Abstract][Full Text] [Related]
77. The efficacy and real-world effectiveness of a diet low in fermentable oligo-, di-, monosaccharides and polyols in irritable bowel syndrome: A systematic review and meta-analysis.
Jent S; Bez NS; Haddad J; Catalano L; Egger KS; Raia M; Tedde GS; Rogler G
Clin Nutr; 2024 Jun; 43(6):1551-1562. PubMed ID: 38754307
[TBL] [Abstract][Full Text] [Related]
78. Effect of diet and individual dietary guidance on gastrointestinal endocrine cells in patients with irritable bowel syndrome (Review).
Mazzawi T; El-Salhy M
Int J Mol Med; 2017 Oct; 40(4):943-952. PubMed ID: 28849091
[TBL] [Abstract][Full Text] [Related]
79. Long-term personalized low FODMAP diet in IBS.
De Palma G; Bercik P
Neurogastroenterol Motil; 2022 Apr; 34(4):e14356. PubMed ID: 35293089
[TBL] [Abstract][Full Text] [Related]
80. Study protocol of the Bergen brain-gut-microbiota-axis study: A prospective case-report characterization and dietary intervention study to evaluate the effects of microbiota alterations on cognition and anatomical and functional brain connectivity in patients with irritable bowel syndrome.
Berentsen B; Nagaraja BH; Teige EP; Lied GA; Lundervold AJ; Lundervold K; Steinsvik EK; Hillestad ER; Valeur J; Brønstad I; Gilja OH; Osnes B; Hatlebakk JG; Haász J; Labus J; Gupta A; Mayer EA; Benitez-Páez A; Sanz Y; Lundervold A; Hausken T
Medicine (Baltimore); 2020 Sep; 99(37):e21950. PubMed ID: 32925728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
